These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23648014)

  • 1. Adult stem cells for chronic lung diseases.
    Mora AL; Rojas M
    Respirology; 2013 Oct; 18(7):1041-6. PubMed ID: 23648014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema.
    Chilosi M; Carloni A; Rossi A; Poletti V
    Transl Res; 2013 Sep; 162(3):156-73. PubMed ID: 23831269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of mesenchymal stem cell therapy for chronic lung disease.
    Cruz FF; Rocco PRM
    Expert Rev Respir Med; 2020 Jan; 14(1):31-39. PubMed ID: 31608724
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease.
    D'Agostino B; Sullo N; Siniscalco D; De Angelis A; Rossi F
    Expert Opin Biol Ther; 2010 May; 10(5):681-7. PubMed ID: 20384521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells and inflammatory lung diseases.
    Iyer SS; Co C; Rojas M
    Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary Diseases and Ageing.
    Barnes PJ
    Subcell Biochem; 2019; 91():45-74. PubMed ID: 30888649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
    Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
    Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated ageing of the lung in COPD: new concepts.
    Mercado N; Ito K; Barnes PJ
    Thorax; 2015 May; 70(5):482-9. PubMed ID: 25739910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
    Faner R; Rojas M; Macnee W; Agustí A
    Am J Respir Crit Care Med; 2012 Aug; 186(4):306-13. PubMed ID: 22582162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of marrow mesenchymal stem cell transplantation on pulmonary fibrosis in rats].
    Huang K; Wu XM; Wang XY; Kang XW; Xiao JL; Li ZG; Lu P
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):659-64. PubMed ID: 23158067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
    Gharaee-Kermani M; Gyetko MR; Hu B; Phan SH
    Pharm Res; 2007 May; 24(5):819-41. PubMed ID: 17333393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.
    Inamdar AC; Inamdar AA
    Exp Lung Res; 2013 Oct; 39(8):315-27. PubMed ID: 23992090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors.
    Guan XJ; Song L; Han FF; Cui ZL; Chen X; Guo XJ; Xu WG
    J Cell Biochem; 2013 Feb; 114(2):323-35. PubMed ID: 22949406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific subsets of mesenchymal stroma cells to treat lung disorders--finding the Holy Grail.
    Rolandsson S; Karlsson JC; Scheding S; Westergren-Thorsson G
    Pulm Pharmacol Ther; 2014 Dec; 29(2):93-5. PubMed ID: 25239767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell trials for pulmonary diseases.
    Antunes MA; Laffey JG; Pelosi P; Rocco PR
    J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury.
    Kumamoto M; Nishiwaki T; Matsuo N; Kimura H; Matsushima K
    Eur Respir J; 2009 Sep; 34(3):740-8. PubMed ID: 19324956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell therapy in pulmonary fibrosis.
    Tzouvelekis A; Antoniadis A; Bouros D
    Curr Opin Pulm Med; 2011 Sep; 17(5):368-73. PubMed ID: 21681099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of cellular therapy in respiratory diseases.
    Abreu SC; Antunes MA; Pelosi P; Morales MM; Rocco PR
    Intensive Care Med; 2011 Sep; 37(9):1421-31. PubMed ID: 21656291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.
    Conese M; Carbone A; Castellani S; Di Gioia S
    Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging and lung injury repair: a role for bone marrow derived mesenchymal stem cells.
    Mora AL; Rojas M
    J Cell Biochem; 2008 Oct; 105(3):641-7. PubMed ID: 18759327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.